FDA announcements or credible healthcare regulatory updates

Hims & Hers Health Adds Compounded GLP-1 Injections to Weight Loss Program, Stock Surges 38%

May 20, 2024, 04:09 PM

Hims & Hers Health announced it will add compounded GLP-1 injections to its weight loss program. The digital pharmacy startup aims to offer these injectable weight-loss drugs, similar to Ozempic and Wegovy, at a discounted price of $199 per month, significantly lower than the nearly $1,000 retail price of Ozempic. This move is expected to make popular weight-loss treatments more accessible to telehealth patients through its telehealth platform. Following the announcement, Hims & Hers Health's stock surged, with shares jumping as much as 38% on the news, highlighting the big market potential.